Modulation of one of the most important blood cells involved in the human immune response may effectively treat and prevent the symptoms of type 2 diabetes and periodontitis simultaneously, scientists say. Researchers have found that B cells, blood cells involved in the human immune response, promote inflammation and bone loss in type 2 diabetes-associated periodontal disease. These findings support the idea that treatments that manipulate the responses of B cells may treat or prevent this complication. "Our study identified common inflammatory mechanisms shared by type 2 diabetes and periodontal disease. It paves the way for the development of novel therapeutics which aim to simultaneously treat both type 2 diabetes and its complications," said Min Zhu, a researcher involved in the work from the department of microbiology at Boston University School of Medicine in Boston, Massachusetts. To make this discovery, scientists used an experimental model (mouse model) of periodo...
Comments
Post a Comment